During the past decade, Utah Cancer Specialists-Salt Lake City conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 53 clinical trials were completed, i.e. on average, 70.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 31 clinical trials were completed. i.e. 182.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Utah Cancer Specialists-Salt Lake City" #1 sponsor was "National Cancer Institute (NCI)" with 62 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Utah Cancer Specialists-Salt Lake City" #1 collaborator was "National Cancer Institute (NCI)" with 66 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Radiation Therapy Oncology Group" with 7 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Utah Cancer Specialists-Salt Lake City" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Cervical Adenocarcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Fallopian Tube Transitional Cell Carcinoma" (6 trials) and "Ovarian Transitional Cell Carcinoma" (6 trials). Many other conditions were trialed in "Utah Cancer Specialists-Salt Lake City" in a lesser frequency.

Most popular intervention types in "Utah Cancer Specialists-Salt Lake City" are "Drug" (101 trials), "Other" (88 trials), "Biological" (53 trials), "Radiation" (39 trials) and "Procedure" (33 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (50 trials), "Quality-of-Life Assessment" (39 trials), "Paclitaxel" (21 trials), "Questionnaire Administration" (21 trials) and "Computed Tomography" (17 trials). Other intervention names were less common.

The vast majority of trials in "Utah Cancer Specialists-Salt Lake City" are 91 trials for "All" genders, 29 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Utah Cancer Specialists-Salt Lake City". undefined are not yet recruiting, 19 are recruiting, 68 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Utah Cancer Specialists-Salt Lake City, 3 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Utah Cancer Specialists-Salt Lake City, 4 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".